Company Performance: Financial health, revenue growth, profitability, and debt levels directly influence investor confidence and stock price.

Industry Trends: The performance and outlook of the pharmaceutical industry, including competitor activity, regulatory changes, and technological advancements, impact stock valuation.

Market Sentiment: Overall investor mood and risk appetite within the South Korean stock market can cause price fluctuations, regardless of the company's fundamentals.

Economic Conditions: Macroeconomic factors such as interest rates, inflation, and GDP growth in South Korea can affect corporate earnings and investment decisions.

Global Events: International events, including geopolitical tensions and global economic trends, can create uncertainty and affect investor sentiment.

Regulatory Environment: Changes in pharmaceutical regulations, drug pricing policies, and healthcare reforms in South Korea can impact revenue and profitability.

News and Announcements: Positive or negative news related to the company, such as drug approvals, clinical trial results, or acquisitions, can trigger significant price movements.

Dividend Policy: The company's dividend payout ratio and any changes to it can influence investor demand and stock price.

Analyst Ratings: Investment analysts' reports and ratings on the stock can shape investor expectations and trading activity.

Currency Fluctuations: Changes in the value of the Korean Won relative to other currencies can affect the company's earnings, especially if it has significant international operations.